Page last updated: 2024-10-27

fleroxacin and Anorectal Diseases

fleroxacin has been researched along with Anorectal Diseases in 1 studies

Fleroxacin: A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
fleroxacin : A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.

Research Excerpts

ExcerptRelevanceReference
"We conducted clinical studies on fleroxacin (FLRX), a new pyridone carboxylic acid derivative, for the treatment of periproctal abscess, secondary infections (due to wounds, burns or surgical operations), mastitis or areolitis and others with once daily dose of 200 mg or 300 mg."3.68[Clinical study on fleroxacin in surgical infections]. ( Ishikawa, M; Ishikawa, S; Kinoshita, H; Mashita, K; Mizuno, A; Morimoto, K; Sakai, K; Shinagawa, N; Suzuki, T; Yura, J, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yura, J1
Shinagawa, N1
Ishikawa, S1
Mashita, K1
Kinoshita, H1
Morimoto, K1
Sakai, K1
Mizuno, A1
Ishikawa, M1
Suzuki, T1

Other Studies

1 other study available for fleroxacin and Anorectal Diseases

ArticleYear
[Clinical study on fleroxacin in surgical infections].
    The Japanese journal of antibiotics, 1991, Volume: 44, Issue:6

    Topics: Abscess; Administration, Oral; Adolescent; Adult; Aged; Bacteria; Ciprofloxacin; Drug Resistance, Mi

1991